ClinicalTrials.Veeva

Menu

Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically (EPI-LoVE)

University of California, Los Angeles (UCLA) logo

University of California, Los Angeles (UCLA)

Status

Enrolling

Conditions

HIV Infections

Treatments

Other: EPI LOVE

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06370780
23-000477
5UG3AI176592-02

Details and patient eligibility

About

Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.

Full description

This study will follow a digital cohort via the REMAIN App. The REMAIN App is adapted from the HealthMPowerment (HMP) platform and tailored to our focus population's unique needs. Digital cohorts, or eCohorts, utilize the flexibility and capacity of the internet to complement traditional approaches to epidemiological research, helping address some of the limitations and challenges associated with conventional cohort studies.

Aim 1 of this study is to recruit and retain a geographically and demographically diverse cohort of PLWH who are sub optimally engaged in care and with a history of, at high risk for, or not currently virally suppressed. Outcomes for this are levels of recruitment and retention to hit the study objectives to enroll 1,000 PLWH at risk for or experiencing VNS and follow them for up to 48 months. Aim 2 is to evaluate longitudinal patterns of care engagement within the cohort by modeling and advanced epidemiologic methods utilizing remote collection of biomarkers of HIV disease (e.g., viral load), online surveys, and brief, frequent app-based "check-ins". Outcomes include both those related to VS and engagement in care as well as engagement in the digital cohort.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Have access to a personal smartphone device;
  • Over 18 years of age;
  • Speak English or Spanish;
  • Living with HIV
  • Are either 1) not currently virally suppressed, 2) not currently engaged in care, or 3) have one or more factors associated with viral non suppression including a history of missed appointments or viral non suppression;
  • Active substance use or mental health disorder;
  • Willing and able to provide written informed consent to take part in the study.

Exclusion criteria

  • Unwilling or unable to provide reliable contact information;
  • Unwilling to provide blood sample for HIV virology testing;
  • Living with HIV and virally suppressed and not at risk of becoming unsuppressed in the near future.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1,000 participants in 1 patient group

Download the REMAIN App
Other group
Description:
All participants download the app
Treatment:
Other: EPI LOVE

Trial contacts and locations

1

Loading...

Central trial contact

Pamina Gorbach, DrPh; Valerie El-Alfi, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems